iSpecimen Inc. (NASDAQ:ISPC – Get Free Report) traded down 8.2% on Wednesday . The stock traded as low as $0.27 and last traded at $0.27. 394,523 shares changed hands during mid-day trading, a decline of 81% from the average session volume of 2,078,512 shares. The stock had previously closed at $0.29.
iSpecimen Price Performance
The business’s 50 day simple moving average is $0.32 and its 200-day simple moving average is $0.38. The stock has a market capitalization of $3.54 million, a P/E ratio of -0.21 and a beta of 1.60.
iSpecimen (NASDAQ:ISPC – Get Free Report) last posted its quarterly earnings results on Tuesday, May 7th. The company reported ($0.32) earnings per share for the quarter. iSpecimen had a negative net margin of 124.84% and a negative return on equity of 105.25%. The company had revenue of $2.29 million during the quarter.
About iSpecimen
iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.
Further Reading
- Five stocks we like better than iSpecimen
- How to Find Undervalued Stocks
- AbbVie Stock: A Perfect Dip for Investors to Buy
- With Risk Tolerance, One Size Does Not Fit All
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- How to buy stock: A step-by-step guide for beginners
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter.
